TABLE 3.
Baseline values and change scores at 4 and 6 mo for primary and secondary outcome variables by treatment group1
C-WL group | HP-WL group | ||||
---|---|---|---|---|---|
Mean ± SD | P 2 | Mean ± SD | P 2 | P (C-WL vs. HP-WL) | |
Primary outcomes | |||||
6MWT, m | |||||
Baseline | 478.7 ± 79.3 | 494.1 ± 86.1 | |||
Change at 4 mo | 23.2 ± 54.4 | 0.09 | 45.2 ± 61.1 | <0.001 | 0.19 |
Change at 6 mo | 46.8 ± 89.0 | 0.01 | 56.9 ± 68.0 | <0.001 | 0.58 |
Lean body mass, kg | |||||
Baseline | 51.1 ± 6.2 | 49.0 ± 7.3 | |||
Change at 4 mo | −0.8 ± 1.0 | <0.01 | −0.8 ± 1.0 | <0.001 | 0.87 |
Change at 6 mo | −1.0 ± 1.1 | <0.001 | −0.6 ± 1.1 | <0.01 | 0.20 |
Secondary outcomes | |||||
Body weight, kg | |||||
Baseline | 103.0 ± 15.6 | 98.6 ± 18.6 | |||
Change at 4 mo | −5.7 ± 3.2 | <0.001 | −5.2 ± 3.9 | <0.001 | 0.70 |
Change at 6 mo | −6.4 ± 4.9 | <0.001 | −6.2 ± 5.9 | <0.001 | 0.92 |
Body weight, % | |||||
Change at 4 mo | −5.6 ± 3.3 | <0.001 | −5.2 ± 4.0 | <0.001 | 0.77 |
Change at 6 mo | −6.3 ± 4.8 | <0.001 | −6.2 ± 5.3 | <0.001 | 0.92 |
Lean body mass, % | |||||
Change at 4 mo | −1.5 ± 1.9 | 0.07 | −1.0 ± 4.1 | 0.11 | 0.62 |
Change at 6 mo | −1.9 ± 2.0 | 0.03 | −0.5 ± 4.5 | 0.49 | 0.17 |
Fat mass, kg | |||||
Baseline | 51.9 ± 11.9 | 49.4 ± 13.0 | |||
Change at 4 mo | −4.9 ± 3.2 | <0.001 | −4.1 ± 3.8 | <0.001 | 0.45 |
Change at 6 mo | −5.9 ± 3.7 | <0.001 | −5.2 ± 5.2 | <0.001 | 0.68 |
Fat mass, % | |||||
Change at 4 mo | −2.2 ± 1.9 | <0.001 | −2.0 ± 2.1 | <0.001 | 0.68 |
Change at 6 mo | −2.7 ± 2.3 | <0.001 | −2.7 ± 2.8 | <0.001 | 0.81 |
SPPB total, 0–12 | |||||
Baseline | 10.1 ± 1.5 | 10.2 ± 1.5 | |||
Change at 4 mo | 1.2 ± 1.0 | <0.001 | 0.9 ± 1.4 | <0.001 | 0.68 |
Change at 6 mo | 1.2 ± 1.0 | <0.001 | 1.0 ± 1.4 | <0.001 | 0.94 |
SPPB balance, 0–4 | |||||
Baseline | 3.8 ± 0.6 | 3.9 ± 0.4 | |||
Change at 4 mo | 0.2 ± 0.8 | 0.20 | −0.03 ± 0.4 | 0.37 | 0.65 |
Change at 6 mo | 0.2 ± 0.8 | 0.38 | −0.03 ± 0.5 | 0.85 | 0.55 |
SPPB gait speed, 0–4 | |||||
Baseline | 3.8 ± 0.6 | 3.8 ± 0.4 | |||
Change at 4 mo | 0.05 ± 0.4 | 0.12 | 0.1 ± 0.3 | <0.01 | 0.52 |
Change at 6 mo | 0.2 ± 0.4 | 0.11 | 0.1 ± 0.4 | <0.01 | 0.82 |
SPPB chair stands, 0–4 | |||||
Baseline | 2.5 ± 1.0 | 2.6 ± 1.2 | |||
Change at 4 mo | 1.0 ± 0.8 | <0.001 | 0.8 ± 1.1 | <0.001 | 0.80 |
Change at 6 mo | 0.9 ± 1.0 | <0.001 | 1.0 ± 1.1 | <0.001 | 0.62 |
Waist circumference, cm | |||||
Baseline | 104.7 ± 10.0 | 102.5 ± 11.6 | |||
Change at 4 mo | −4.6 ± 3.7 | <0.001 | −4.2 ± 4.2 | <0.001 | 0.66 |
Change at 6 mo | −7.4 ± 3.8 | <0.001 | −6.0 ± 3.3 | <0.001 | 0.19 |
8-Foot up-and-go, s | |||||
Baseline | 7.9 ± 2.3 | 7.8 ± 1.7 | |||
Change at 4 mo | −0.9 ± 1.9 | 0.01 | −0.6 ± 1.3 | 0.01 | 0.71 |
Change at 6 mo | −0.6 ± 1.5 | 0.01 | −1.2 ± 1.8 | <0.001 | 0.26 |
30-s Chair stands, n | |||||
Baseline | 11.2 ± 3.1 | 11.2 ± 2.7 | |||
Change at 4 mo | 1.1 ± 2.1 | <0.01 | 1.6 ± 1.8 | <0.001 | 0.59 |
Change at 6 mo | 1.2 ± 3.1 | 0.06 | 1.9 ± 2.9 | <0.01 | 0.84 |
Between- and within-group differences were detected by using mixed-model repeated-measures ANOVA with baseline values as covariates. C-WL, Control–Weight-Loss; HP-WL, High-Protein–Weight-Loss; SPPB, Short Physical Performance Battery; 6MWT, 6 Minute Walk Test.
P values for within-group change from baseline to 4 and 6 mo.